Novakand Pharma AB (publ) (LARK) — Free Cash Flow Generation Index
Novakand Pharma AB (publ) (LARK) has a Free Cash Flow Generation Index of 1.00x as of September 2022. Free cash flow of Skr379.00K represents 1% of operating cash flow (Skr379.00K). For the full cash flow conversion analysis, see Novakand Pharma AB (publ) (LARK) cash conversion ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novakand Pharma AB (publ) Free Cash Flow Generation Index (2012–2021)
Historical FCF Generation Index trend for Novakand Pharma AB (publ) across 3 annual periods. Check LARK cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Free Cash Flow Generation for Novakand Pharma AB (publ) (2012–2021)
Year-by-year Free Cash Flow Generation Index for Novakand Pharma AB (publ). Explore Novakand Pharma AB (publ) (LARK) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.99x | Skr21.97 Million | Skr22.11 Million | Skr147.73K | ▲ +211.6% |
| 2018 | -0.89x | Skr-202.60K | Skr227.60K | Skr430.20K | ▼ -189.0% |
| 2012 | 1.00x | Skr59.21K | Skr59.21K | Skr0.00 | — |